TY - JOUR AU - Bogari, Neda M. AU - Aljohani, Ashwag AU - Amin, Amr A. AU - Al-Allaf, Faisal A. AU - Dannoun, Anas AU - Taher, Mohiuddin M. AU - Elsayed, Atalla AU - Rednah, Dareen ibrahim AU - Elkhatee, Osama AU - Porqueddu, Massimo AU - Alamanni, Francesco AU - Khogeer, Soud Abdulraof A. AU - Fawzy, Ahmed PY - 2019 DA - 2019/01/03 TI - A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug JO - BMC Cardiovascular Disorders SP - 2 VL - 19 IS - 1 AB - Elevated plasma triglycerides (TGs) are widely used as a major cardiovascular risk predictor and are thought to play an important role in the progression of coronary heart disease (CHD). It has been demonstrated that lipid lowering was associated with lower mortality in patients with CHD. The present study therefore aimed to investigate the consequences of the genetic variant c.553G > T (rs2075291) in apolipoprotein A5 gene to determination of triglycerides levels in CAD patients receiving, atorvastatin, lipid lowering drug. SN - 1471-2261 UR - https://doi.org/10.1186/s12872-018-0965-3 DO - 10.1186/s12872-018-0965-3 ID - Bogari2019 ER -